Introduction If you asked us (and many other industrial consultants) what is one of the most common commercial strategy mistake we see in otherwise well-positioned early stage companies - without a doubt it would …
We spoke in detail about our activities at BeyondBiotech podcast, you can listen to the episode here: https://podcast.labiotech.eu/1995493/episodes/16219760-cracking-the-code-of-biotech-valuations
The new managed entry agreement (MEA) and health technology assessment (HTA) regulations adopted in Ukraine over the course of 2020 and 2021 present significant step forward in improving access to treatment in the country. …